Paweł Bogdański
Researcher Next ID · RN-041625
Researcher · Medicine
Poznan University of Medical Sciences
Poznan, Poland
- Works count
- 451
- Citation count
- 7,437
- H-index
- 46
- i10-index
- 149
Research interests
Publications
Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac So
Archives of Medical Science · 2022 · https://doi.org/10.5114/aoms/152921
You Are What You Eat—The Relationship between Diet, Microbiota, and Metabolic Disorders—A Review
Nutrients · 2020 · https://doi.org/10.3390/nu12041096
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
The Lancet Diabetes & Endocrinology · 2019 · https://doi.org/10.1016/s2213-8587(19)30192-5
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
Diabetes Care · 2019 · https://doi.org/10.2337/dc19-0898
Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients
Nutrition Research · 2012 · https://doi.org/10.1016/j.nutres.2012.05.007
Current projects
No projects listed.